We have previously reported that infection of 9-to 13-day-old chicken embryos with RAV-1 results in rapid development of a novel B-cell lymphoma in which proviral insertion has activated expression of the c-myb gene (E. Pizer and E. H. Humphries, J. Virol. 63:1630Virol. 63: -1640Virol. 63: , 1989. The biological properties of these B-cell lymphomas are distinct from those associated with the B-cell lymphomas that develop following avian leukosis virus proviral insertion within the c-myc locus. In an extension of this study, more than 200 chickens, infected as 10-to 11-day-old embryos, were examined for development of lymphomas that possess disrupted c-myb loci. Fourteen percent developed disseminated B-cell lymphoma. In the majority of these tumors, the RAV-1 provirus had inserted between the first and second exons that code for p75c-myb. However, insertions between the second and third exons and between the third and fourth exons were also detected. 
The avian leukosis viruses (ALV) are a family of retroviruses that cause, among other diseases, two distinct avian B-cell lymphomas (21, 41) . One tumor, lymphoid leukosis, develops following ALV infection of hatchling chickens, proviral insertion within the locus encoding the cellular proto-oncogene c-myc, and deregulation of c-myc expression (20, 29, 36) . Microscopic examination of bursal tissue 2 to 4 weeks after infection reveals the presence of pyroninophilic preneoplastic lesions designated transformed follicles (3, 12, 32) . It is believed that these lesions originate following clonal expansion of a specific target cell in which proviral disruption of the c-myc locus has led to unregulated proliferation. Support for this model can be found in the observation that infection of early bursal stem cells with HB-1, a defective acute oncogenic virus that encodes v-myc, results in formation of transformed follicles when the infected cells are used to repopulate chemically ablated bursae (31) . Preneoplastic lesions persist during a latent period lasting between 10 and 15 weeks. In typical cases of lymphoid leukosis, a large tumor nodule is found in the bursa of Fabricius within 2 to 3 months (12, 41 5.5) containing 0.5 mg of diaminobenzidine (Sigma) per ml and 0.005% H202. The reaction was terminated by rinsing in water; counterstaining with 1% methyl green was performed prior to mounting if indicated. The monoclonal antibody against chicken IgM has been previously described (4) . The monoclonal antibody against myb proteins, myb 2.7, was obtained from J. M. Bishop (University of California, San Francisco). Its reactivity has been described previously (15, 39) .
Tumor transfer protocols and cyclophosphamide treatment. Cell suspensions were prepared from tumors and bursa by extrusion of tissue through nylon mesh into DMEM and 1% fetal calf serum. Bone marrow cells were prepared by flushing medium through femurs followed by centrifugation on Ficoll (Isolymph; Gallard-Schlesinger, Carle Place, N.Y.) gradients to remove erythrocytes. Cells were washed twice and resuspended in DMEM at between 0.5 x 107 and 2 x 107/ml. Activated tumor myb transfer recipients, between 6 days and 4 weeks of age, received between 0.1 and 0.5 ml of cell suspension by injection into the jugular vein. Most recipients were injected intraperitoneally with 3 mg of cyclophosphamide (Cytoxan; Mead Johnson, Syracuse, N.Y.) daily for 4 days after hatching to eliminated resident B lymphocytes. Activated myc tumor transfer recipients, 1 day to 2 weeks old, received approximately 107 cells injected into the leg vein. All recipients were normal.
Culture conditions for tumor explants. Single cell suspensions from bursae, bone marrow, and tumors from livers of lymphomatous birds were diluted into Hahn's medium (1) and cultured at 37°C with 10% CO2. Cultures were monitored daily for growth and fed at 6-day intervals by removal of medium and replacement with fresh medium. Cultures that contained no growing cells after 3 weeks were discarded.
Analysis of DNA. Cellular DNA was isolated from cells and tissues as previously described (2) . Restriction enzymes (Boehringer Mannheim Biochemicals, Indianapolis, Ind.) were used in digestion conditions specified by the manufacturer. Analysis of DNA by agarose gel electrophoresis, Southern transfer, and hybridization was done as previously described (2 (13) or were mapped in clone 121: Sm, SmaI; N, Notl; Sc, Sacl; P, PstI. Proviral insertion sites are depicted as arrows below the line, with the hatch cohort and chicken numbers of the animals from which tumors were collected. RESULTS RAV-1 insertional mutagenesis occurs in three different locations within the c-myb locus. In our previous study, 11 tumors bearing RAV-1 proviral insertions within the c-myb locus were described. All insertions were located 5' of UE2 (39) . An additional 19 tumors containing disrupted c-myb loci have been analyzed. Consistent with our previous findings, 13 contained proviral insertions 5' of UE2 (Fig. 1) . In contrast, one insertion was located between UE2 and UE1, while another five were located between UE1 and VE1. These insertions were mapped by both Southern and polymerase chain reaction analysis. Five of seven tumors in hatch 95 contain RAV-1 insertions 5' of VEL. We have no experimental data that provide an explanation for the high frequency of these distinct integrations occurring in a single experiment. As presented earlier, the bursae in all of these additional tumor-bearing birds appeared normal in size and follicular structure, including the cortical medullary border. Southern analysis revealed, however, that a major fraction of the constituent tissue was clonally derived lymphoma as defined by an altered c-myb locus. Histological analysis with MGP revealed that the majority of bursal lymphocytes were pyroninophilic and similar to cells within the preneoplastic lesion, the transformed follicle, observed during development of lymphomas expressing elevated levels of myc. In contrast to the activated-myb lymphoma, the transformed follicle expands locally into a primary tumor that disrupts the follicular architecture. Histological examples of a normal bursa, a transformed follicle from a posthatch RAV-1-infected chick, as well as primary c-myb-activated and c-mycactivated lymphomas are shown in Fig. 2 .
In situ analysis of myb protein expression in tumor tissue reveals nondestructive metastatic growth within the bursa and modulation of myb expression in the periphery of liver nod- revealed that a large fraction of thymocytes was stained and also that the highest density of darkly stained cells was detected in the subcapsular cortex. The staining of normal bursa ( Fig. 3C and D) revealed high c-myb expression in a small number of cells located mostly in the cortex. The relative amounts of anti-myb staining in normal thymus and bursa were consistent with levels of c-myb mRNA detected in these organs (18, 39, 45) . The vast majority of normal bursal lymphocytes exhibited no detectable c-myb antigen. In contrast, staining of sections of bursae from activatedmyb tumor-bearing chickens revealed elevated myb expression in a large fraction of cells (Fig. 3E and F ). These bursae contained (i) follicles that were filled with intensely stained cells, (ii) follicles in which the cortex had expanded and filled with intensely stained cells while the medulla possessed cells expressing lower levels of myb antigen, and (iii) follicles apparently structurally unaltered that contained intensely stained cells only in the cortex. The appearance of these follicles suggested that they were filling with tumor at the time of sacrifice. There were also follicles that appeared degenerate, with little remaining structure and with heterogeneous lower levels of myb expression. Examination of the c-myb locus demonstrated that bursal tumor cells had a clonal origin (39; data not shown). These histology data confirm the MGP staining analysis of bursal tissue and suggest that activated myb lymphoma metastasizes from follicle to follicle without compromising follicular structural integrity. Furthermore, the cells are responsive to their anatomical locations, since they fill follicular but not interstitial spaces, and apparently recognize cortical and medullary microenvironments. The histology further suggests that the tumor locates first in the cortex of follicles indicating the tumor uses the same trafficking mechanisms that normal lymphocytes use to exit the bursa or that stem cells use to populate it (22, 27) .
Twenty-three individual tumors from liver were stained with myb 2.7. Figure 4 illustrates some characteristic features of the myb reactivity observed. Serial sections of tumor tissue were stained with anti-myb and anti-chicken The amount of myb antigen in both lymphoma tissue and normal lymphoid organs is consistent with previously reported levels of myb mRNA in these tissues; RNA expression in lymphoma cells and thymocytes is comparable and much higher than in normal bursal B cells (10, 18, 39) . Heterogeneity of staining intensity for myb is a feature of populations of both thymocytes and lymphoma cells. It may reflect differences in proliferative capacity or in differentiation state of the cells.
Activated-myb lymphoma is transplantable at low frequency and does not readily proliferate in vitro. Transplantation of tumors into recipient animals can be used as an assay to study a tumor's growth properties. Suspension of tumor cells from liver, bursa, or bone marrow were prepared from six chickens with activated myb lymphoma ( Table 1) . Cell suspensions were placed into in vitro culture. No in vitro growth was observed in any culture. Additionally, between 106 and 107 cells were injected intravenously into normal or cyclophosphamide-treated recipient chickens (14, 40) . After 2 weeks of incubation, recipient chickens were sacrificed, and bursae and livers were examined grossly for evidence of tumor. Of 10 tumor cell suspensions transferred into 31 recipients, only tumor 86-86 gave rise to a successful transplant. Transplant recipient 185 was transferred into 12 secondary recipients. The tumor grew successfully only in recipient 105. A tertiary in vivo transfer into eight recipients was performed in which successful transplantation occurred in seven of the recipients, including recipients that were not cyclophosphamide treated. Six of these chickens died prior to the scheduled termination of the in vivo transfer step. Tumor from the seventh chicken, recipient 117, was transferred into five recipients, all of which succumbed to the tumor within 5 days of transfer. At each transfer, tumor reisolated from recipients was examined by Southern analysis and shown to contain the same viral myb junction fragments observed in tumor 86-86. At each transfer, approximately 5 x 106 cells were placed in culture for in vitro proliferation. In no case was proliferation observed. These studies indicate that the activated-myb tumor transplants inefficiently in vivo and may not be capable of in vitro proliferation. In contrast, a similar study has demonstrated that the activated-myc tumor grew successfully after most transfers and that several cell lines were successfully developed (Table 2 ) (1). While these studies differed in some experimental details, it appeared that the myc tumor was biologically distinct with respect to these properties.
Elevated expression of myb protein is not sufficient for development of activated-myb lymphoma. Activated-myb lymphoma develops rapidly, reaching an end-stage disease 3 to 7 weeks posthatch, or 4 to 8 weeks postinfection. This schedule suggested two corollaries: (i) activation of c-myb is the single rate-limiting event required for lymphoma development, and (ii) growth of the initial lymphoma is metastatic and bursa independent. However, both the apparent down modulation of myb antigen in peripheral tumor nodules and the very low efficiency of transplantability of the lymphoma suggested that the requirements for tumor growth might be more complex. To address this issue, we examined bursal tissue from RAV-1-infected chickens not at risk for development of activated myb lymphoma. These were of two types: embryonically infected chickens that did not develop lymphoma and chickens infected posthatch that are not at risk for activated myb lymphoma. The overall incidence of activated-myb lymphoma in the embryonically infected chickens in this study was 14%. Of 207 chickens surveyed, 28 had lymphoma with RAV-1 insertions in the c-myb locus confirmed by Southern analysis. Since tumor incidence was below 25% in every cohort, it can be assumed that in an were 11 and 10%, respectively. Apparently the tumors developed rapidly enough that incubating subclinical disease was negligible by 4 weeks. Therefore, chickens examined at than 48 days (23). In contrast, there was a 79% tumor incidence in those birds that died or were sacrificed in a morbid state between 27 and 48 days (between 3 and 6 weeks posthatch). We analyzed 19 bursae from tumor-free, embryonically infected chickens sacrificed between 4 and 6 weeks after hatch by collection of serial frozen sections at 400-p.m intervals through the entire bursa in order to sample the great majority of follicles from each bursa. Adjacent bursal sections were stained with MGP or for expression of myb antigen or IgM. This analysis revealed that a majority of 4-to 6-week-old bursae from tumor-free chicks contained lesions that expressed abnormal levels of myb ( Table 3) . The lesions were similar to those in bursae of chickens with activatedmyb lymphoma. Two distinct lesions were observed. The first class consisted of follicles with high-level myb expression that occurred in clusters, suggesting a nascent tumor demonstrating follicle-to-follicle spread (Fig. 5A to C) . The second class consisted of isolated follicles filled with cells that overexpressed myb antigen to various degrees (Fig. 5D to F). Only three bursae (16%) appeared not to contain any myb-overexpressing lesions. Eleven of nineteen bursae (58%) contained clustered myb-overexpressing follicles as well as numerous isolated follicle lesions. With an overall tumor incidence of 14%, we conclude that most of the lesions observed that expressed abnormally high levels of myb antigen would not have progressed into activated-myb lymphomas. It is important to note that DNA prepared from four of these bursae was analyzed by polymerase chain reaction and shown to have RAV-1 insertions within the c-myb locus (data not shown). It is apparent that a majority of the myb activation events did not result in lesions capable of clonal expansion and the development of tumors of clinically significant size.
A second and independent line of evidence indicated activation of myb expression was insufficient for tumor development. As suggested by the requirement for embryonic infection, activation of the expression of myb and the subsequent development of a B-cell lymphoma appear to require infection of a specific target cell. It was possible, therefore, that activation of myb expression in an inappropriate cell might occur but not progress to lymphoma. To address this issue, four bursae from chickens infected with RAV-1 on the day after hatch and sacrificed 2 weeks after infection were serially sectioned and analyzed for expression of myb. All four bursae contained follicles that overexpressed myb. These follicles were visually indistinguishable from follicles found in embryonically infected bursae. The follicles resembled those shown in Fig. 5E and F. No follicle cluster lesions were found. Most of the myb-expressing lesions in these bursae had lower levels of myb antigen than did average lesions in embryonically infected bursae.
A primary bursal tumor containing both disrupted c-myb and c-myc loci behaves like a tumor expressing elevated levels of myc. Chicken 70-63 was infected with RAV-1 on the day after hatch and sacrificed 18 weeks later. The bursa contained two distinct encapsulated bursal nodules, each of approximately 1 cm in diameter, as well as abundant lymphoma in the liver. Southern analysis of liver tumor DNA revealed a proviral insertion in c-myc and unaltered c-myb alleles consistent with typical lymphoid leukosis. Surprisingly, when the bursa was sectioned and stained with antimyb antibody, one of the nodules (N1) was found to express a low level of myb antigen, while the other (N2) was negative. DNA was extracted from the remnants of each nodule. Digestion with BamHI and hybridization to the 5.4-kb EcoRI germ line c-myb fragment containing c-myb exons UE2 through VE2 as previously described (39) confirmed that the abdominal lymphoma in chicken 70-63 had unaltered c-myb alleles, as did the bursal nodule that did not express myb antigen, N2 (Fig. 6A) . In contrast, Ni expressed myb antigen and possessed a disrupted c-myb allele. Digestion of this DNA with EcoRI (Fig. 6B ) located the disruption in the vicinity of the insertion in the activated myb lymphoma 66-32 DNA (Fig. 1) . The three 70-63 tumor DNA samples were digested with EcoRI and analyzed in duplicate with a c-myc exon 3 probe (Fig. 6C) or with the EcoRI-SacI RAV-1 proviral fragment containing U5 LTR sequences ( Fig. 6D ) (39) . DNA from all three tumor samples contained EcoRI fragments of about 2.7 kb that hybridized with both myc and LTR probes. N2 DNA contained an additional 3.5-kb EcoRI fragment that also hybridized with both probes. DNA from all three tumor samples contained two fragments of about 4.8 and 5.2 kb that hybridized with the RAV-1 LTR probe. Presumably, in the sample from Ni, the altered c-myb fragment comigrated with one of these. These results do not suggest a simple model to explain tumor development in chicken 70-63. The presence of 2.7-, 4.8-, and 5.2-kb junction fragments in all three samples suggests a common origin, yet each sample has unique features. Despite this uncertainty, it is possible to conclude that a disruption of both c-myb and c-myc occurred in cells that gave rise to Ni but that the growth phenotype of Ni was consistent with c-myc activation. Consequently, the disruption of c-myb did not result in rapidly disseminating lymphoma and thus is similar to results for the nonprogressing myb-positive lesions observed in RAV-1-infected chickens.
DISCUSSION
The development of a rapidly disseminating B-cell lymphoma characterized by elevated expression of myb has been examined in 207 chickens. The biological properties of this lymphoma distinguish it from two other avian B-cell lymphomas as described elsewhere (21) . Relevant .,I
/r- (Fig. 1) , two of which contain the full N-terminal region of p75c-mb responsible for binding DNA (9, 16, 19, 26, 48) . All three are less extensively truncated than is typically found in tumorigenically altered myb alleles (24, 25, 44) . Expression of myb proteins in cells with insertional activation of the locus probably results in several transcriptional alterations and provides a pleiotropic effect (35) . Murine B-cell ontogeny is characterized by high levels of c-myb expression early and then down regulation to low levels during differentiation (5, 6) . Presumably, c-myb plays a different role in early and later B cells. The nonprogression of myb lesions in chickens infected on the day of hatch (Fig. 5) , as well as the finding of a tumor that contained an activated myb allele that exhibited activated-myc tumor properties (Fig. 6) , indicates that only specific cells within the B lineage are able to respond to the myb product to produce neoplasia. Indeed, the isolated follicles with highlevel myb expression (Fig. SD to F ) may parallel the transformed follicle, containing cells that lack the capacity to expand out of the follicle. It is possible that more extensive truncation of myb renders it tumorigenic in a wider spectrum of cell types. Regulatory factors present in most cells but not in very early B cells may inactivate normal c-myb.
It is curious that only 14% of the infected birds developed tumors in our study whereas 85% developed tumors in a similar study (23) . Since both studies were conducted with SC chickens, it is suggested that viral proteins or genetic elements influence tumor progression. Results from our study suggest that insertional activation is frequent, but the tumorigenesis process is terminated in more than 80% of those birds at risk.
A partial explanation for the lack of tumor progression observed in this study is suggested by the heterogeneity of myb expression in metastatic disease. It is of interest that myb expression is apparently down regulated in some tumor cells, suggesting that sequences other than those in the LTR are able to regulate expression of the disrupted myb locus.
Tumor tissue in liver was either diffuse or compact. In the former, both positive and negative cells were present. Consistent with variable expression of c-myb in the cell cycle (45) , these cells were randomly distributed throughout the tumor. In contrast, compact tumor tissue showed myb expression localized at the periphery of the nodules, suggesting a nonrandom biological change within the center of tumor nodules. Proliferation of some tumors that express myb is factor dependent (17, 34) . As well, some tumors that are dependent on v-myb expression either differentiate spontaneously or differentiate following inactivation of a temperature-sensitive v-myb at the nonpermissive temperature (7, 8, 28) . Since this lymphoma depends on a target cell that is present at 9 to 13 days of embryogenesis (23, 39) , a time at which diversification of Ig genes is only just beginning (42, 43, 46, 47) , the presence of fully diversified light-chain loci in these lymphomas (23, 39) suggests that differentiation of the tumor can occur. It is possible that with low concentrations of specific factors, differentiation of the activated B-lymphoma within compact nodules occurs and that proliferation is possible only at the exterior of the mass. If dependent on factors for proliferation, disruption of the tumor for transplantation and development of cell lines may result in differentiation and failure in both of these assays. The unique biological properties of activated-myb lymphoma suggest that the development of this tumor may provide a valuable model in which to examine the balance of proliferation and differentiation as they relate to the gene expression induced by c-myb.
